Skip to main content
Erschienen in: Journal of Artificial Organs 2/2018

21.11.2017 | Original Article

Outflow graft anastomosis site design could be correlated to aortic valve regurgitation under left ventricular assist device support

verfasst von: Kei Iizuka, Tomohiro Nishinaka, Yuki Ichihara, Takuma Miyamoto, Kenji Yamazaki

Erschienen in: Journal of Artificial Organs | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Aortic valve regurgitation (AR) is a critical complication during circulatory support with a left ventricular assist device (LVAD). The time-course of AR and related factors, including outflow graft anastomosis site design, were investigated. Twenty-three patients who had continuous-flow LVAD implantation and were supported for more than 6 months were investigated. AR grade (none, 0; trivial, 0.5; mild, 1; mild-moderate, 1.5; moderate, 2; moderate-severe, 2.5; severe, 3) and aortic valve opening were evaluated with echocardiography. Computed tomography was performed to all the patients postoperatively. The angle of the outflow graft to the aorta (O-A angle, parallel 0; tangent 90°, 0–180°), aortic diameter at the anastomosis site, sino-tubular junction (STJ) diameter, distance between the STJ and the anastomosis site, and distance between the anastomosis site and the brachiocephalic artery were measured. The patients’ age was 38 ± 11 years. Support duration was 686 ± 354 days. Mean AR grade after continuous-flow LVAD implantation was increased to around mild and was maintained thereafter. No patient needed any intervention to the aortic valve. The aortic valves of 82.6% of patients were closed continuously. The O-A angle (83 ± 14) was positively correlated with maximum AR grade (p = 0.0095). The O-A angle was significantly smaller in patients with maximum AR grade of 1 or less (77 ± 9°) than in those with 1.5 or greater (94 ± 15°, p = 0.021). The other CT measurements had no correlation with AR grade. In conclusion, the O-A angle was correlated with AR grade progression. The O-A angle appears to be one of the important factors related to AR under continuous-flow LVAD support.
Literatur
1.
Zurück zum Zitat Cowger J, Pagani FD, Haft JW, Romano M, Aaronson KD, Kolias TJ. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail. 2010;3:668–74.CrossRefPubMedPubMedCentral Cowger J, Pagani FD, Haft JW, Romano M, Aaronson KD, Kolias TJ. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail. 2010;3:668–74.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Pak SW, Uriel N, Takayama H, Cappleman S, Song R, Colombo PC, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transpl. 2010;29:1172–6.CrossRef Pak SW, Uriel N, Takayama H, Cappleman S, Song R, Colombo PC, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transpl. 2010;29:1172–6.CrossRef
3.
Zurück zum Zitat Hatano M, Kinugawa K, Shiga T, Kato N, Endo M, Hisagi M, et al. Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. Circ J. 2011;75:1147–55.CrossRefPubMed Hatano M, Kinugawa K, Shiga T, Kato N, Endo M, Hisagi M, et al. Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. Circ J. 2011;75:1147–55.CrossRefPubMed
4.
Zurück zum Zitat Iizuka K, Nishinaka T, Takewa Y, Yamazaki K, Tatsumi E. The influence of pump rotation speed on hemodynamics and myocardial oxygen metabolism in left ventricular assist device support with aortic valve regurgitation. J Artif Organs. 2017;20:194–9.CrossRefPubMed Iizuka K, Nishinaka T, Takewa Y, Yamazaki K, Tatsumi E. The influence of pump rotation speed on hemodynamics and myocardial oxygen metabolism in left ventricular assist device support with aortic valve regurgitation. J Artif Organs. 2017;20:194–9.CrossRefPubMed
5.
Zurück zum Zitat Itoda Y, Nawata K, Yamauchi H, Kinoshita O, Kimura M, Ono M. Central aortic valve closure successfully treated aortic insufficiency of the patient with Jarvik 2000 continuous flow left ventricular assist device: a case report. J Artif Organs. 2017;20:99–101.CrossRefPubMed Itoda Y, Nawata K, Yamauchi H, Kinoshita O, Kimura M, Ono M. Central aortic valve closure successfully treated aortic insufficiency of the patient with Jarvik 2000 continuous flow left ventricular assist device: a case report. J Artif Organs. 2017;20:99–101.CrossRefPubMed
6.
Zurück zum Zitat Benk C, Mauch A, Beyersdorf F, Klemm R, Russe M, Blanke P, et al. Effect of cannula position in the thoracic aorta with continuous left ventricular support: four-dimensional flow-sensitive magnetic resonance imaging in an in vitro model. Eur J Cardio-thoracic Surg. 2013;44:551–8.CrossRef Benk C, Mauch A, Beyersdorf F, Klemm R, Russe M, Blanke P, et al. Effect of cannula position in the thoracic aorta with continuous left ventricular support: four-dimensional flow-sensitive magnetic resonance imaging in an in vitro model. Eur J Cardio-thoracic Surg. 2013;44:551–8.CrossRef
7.
Zurück zum Zitat Yamazaki K, Kihara S, Akimoto T, Tagusari O, Kawai A, Umezu M, et al. EVAHEART: an implantable centrifugal blood pump for long-term circulatory support. Jpn J Thorac Cardiovasc Surg. 2002;50:461–5.CrossRefPubMed Yamazaki K, Kihara S, Akimoto T, Tagusari O, Kawai A, Umezu M, et al. EVAHEART: an implantable centrifugal blood pump for long-term circulatory support. Jpn J Thorac Cardiovasc Surg. 2002;50:461–5.CrossRefPubMed
8.
Zurück zum Zitat Yamazaki K, Saito S, Kihara S, Tagusari O, Kurosawa H. Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump: mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg. 2007;55:158–62.CrossRefPubMed Yamazaki K, Saito S, Kihara S, Tagusari O, Kurosawa H. Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump: mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg. 2007;55:158–62.CrossRefPubMed
9.
Zurück zum Zitat Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transpl. 2013;48:452–8.CrossRef Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transpl. 2013;48:452–8.CrossRef
10.
Zurück zum Zitat Patil NP, Sabashnikov A, Mohite PN, Garcia D, Weymann A, Zych B, et al. De novo aortic regurgitation after continuous-flow left ventricular assist device implantation. Ann Thorac Surg. 2014;98:850–7.CrossRefPubMed Patil NP, Sabashnikov A, Mohite PN, Garcia D, Weymann A, Zych B, et al. De novo aortic regurgitation after continuous-flow left ventricular assist device implantation. Ann Thorac Surg. 2014;98:850–7.CrossRefPubMed
11.
Zurück zum Zitat May-Newman K, Hillen B, Dembitsky W. Effect of left ventricular assist device outflow conduit anastomosis location on flow patterns in the native aorta. ASAIO J. 2006;52:132–9.CrossRefPubMed May-Newman K, Hillen B, Dembitsky W. Effect of left ventricular assist device outflow conduit anastomosis location on flow patterns in the native aorta. ASAIO J. 2006;52:132–9.CrossRefPubMed
12.
Zurück zum Zitat Inci G, Sorgüven E. Effect of LVAD outlet graft anastomosis angle on the aortic valve, wall, and flow. ASAIO J. 2012;58:373–81.CrossRefPubMed Inci G, Sorgüven E. Effect of LVAD outlet graft anastomosis angle on the aortic valve, wall, and flow. ASAIO J. 2012;58:373–81.CrossRefPubMed
Metadaten
Titel
Outflow graft anastomosis site design could be correlated to aortic valve regurgitation under left ventricular assist device support
verfasst von
Kei Iizuka
Tomohiro Nishinaka
Yuki Ichihara
Takuma Miyamoto
Kenji Yamazaki
Publikationsdatum
21.11.2017
Verlag
Springer Japan
Erschienen in
Journal of Artificial Organs / Ausgabe 2/2018
Print ISSN: 1434-7229
Elektronische ISSN: 1619-0904
DOI
https://doi.org/10.1007/s10047-017-1006-1

Weitere Artikel der Ausgabe 2/2018

Journal of Artificial Organs 2/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.